Evidence Synthesis: Risk Factors for Implant Failure

The profession has an enduring fondness for a single villain. Implant dentistry, like every clinical field, prefers a story with one culprit you can name on a consent form: it was the smoking, it was the diabetes, it was that drug the physician started. Nine reviews collected on this site spent considerable statistical effort auditing those stories, and the cumulative finding is mildly deflating for anyone who likes tidy blame. Failure is overwhelmingly a property of the patient rather than the site, it stacks rather than singles out, and several of the named villains turn out to have alibis once you control for the company they keep.

This piece draws on an early anterior-failure cohort, a 468,000-implant veterans cohort, a smoking meta-analysis, a multifactorial bone-loss study, an umbrella review of peri-implantitis risk, a denosumab cohort, a preclinical antidepressant study, a 37,000-patient systemic-disease study and a dental-anxiety pain study.

What the Studies Actually Showed

The single most arresting number is mechanical, not medical. In 2,620 anterior implants, an insertion torque below 30 Ncm carried a hazard ratio (HR) of 13.193 for failure, dwarfing every systemic variable in the model; non-submerged healing (HR 3.000) and dense type I bone (HR 3.220) followed, while bone compression was protective (HR 0.344). In the anterior zone, a low torque reading is not reassurance you can talk yourself out of.

The largest dataset reframes where to even look. Across 468,496 implants in 132,675 veterans over 21 years, the patient-level clustering was extreme: an intraclass correlation coefficient (ICC) of 86%, meaning the patient, not the individual site, drives the outcome. Active periodontitis was the strongest late-failure signal (odds ratio, OR, 2.39), and reimplantation carried 89% higher odds of early failure, the site, in effect, remembering. Smoking earns its reputation in the dedicated meta-analysis, with patient-level survival OR 0.43, roughly 2.5-fold higher failure odds, and 0.64 mm more crestal bone loss. The multifactorial bone-loss study then assembled the maintenance-visit checklist from 404 implants: transmucosal height under 2 mm (OR 4.79), probing depth (PD) at or beyond 6 mm (OR 5.39), absent keratinised mucosa (OR 3.54), an implant-abutment microgap (OR 2.82) and periodontitis history (OR 2.80).

Where They Agree, and Where They Argue

The agreement is structural. Periodontitis history is the most reproducible patient-level signal in the cluster, surviving as an independent factor in the veterans cohort, the bone-loss study and the umbrella review, which states the moral outright: peri-implantitis refuses single-cause stories, and asking which one factor matters most in a patient with several is the wrong question. Risk is an ensemble, and it lives with the person.

The arguments are where the feared villains produce alibis. Smoking is robustly harmful on its own, yet lost statistical significance in the veterans multivariable model and was not independently significant for bone loss once periodontitis and pocketing were controlled. Diabetes follows the same pattern, prevalent and suspected, repeatedly non-significant under adjustment. The drug labels are the sharpest reversal. The veterans cohort flagged alendronate (OR 2.14 for late failure), but the denosumab cohort found survival of 98.08% against 98.24% in controls, no significant difference, and the 37,000-patient systemic study found anti-resorptive use protective against removal, while cerebrovascular and kidney disease, not the osteoporosis drugs everyone frets about, were the load-bearing systemic risks. The antidepressant signal is real but preclinical: bone-to-implant contact fell from 76.89% to 31.44% in rats, with no human failure endpoint, a biological caution, not a contraindication. Even pain behaves predictably: each one-point rise on the Modified Dental Anxiety Scale raised the odds of moderate-to-severe postoperative pain by 38% (OR 1.38), peaking at six hours rather than the 24 we tend to warn about.

Key Findings

• Start the risk assessment with the patient’s history, not the radiograph. Periodontitis history and previous implant loss persist under adjustment where most other factors fade; an ICC of 86% says the person carries the risk.
• In the anterior zone, low torque is the alarm. A hazard ratio above 13 makes insertion torque under 30 Ncm the single loudest predictor in this entire cluster; plan submerged healing or bone compression accordingly.
• Smoking is real, but it travels with periodontitis. It halves survival odds on its own, then shrinks under multivariable adjustment, which means you treat the cluster, not the cigarette in isolation.
• Most feared drug labels do not earn the fear. Osteoporosis-dose anti-resorptive therapy showed comparable or better survival across two large datasets; reflexively contraindicating it is not supported.
• The load-bearing systemic risks are unglamorous. Cerebrovascular and renal disease outranked diabetes and hypertension; screen for the conditions that actually predict removal.
• The honest caveat. The antidepressant evidence is a rat tibia with no clinical endpoint, the largest cohort is an older, mostly male population, and database studies capture removal rather than biological failure. Direction is consistent; mechanism often is not.

💡 The Clinical Bottom Line

Before the next implant consent, look at the patient before the panoramic. Periodontitis history and a prior lost implant deserve more weight than the systemic line items that dominate the conversation, and in the anterior zone a torque wrench reading under 30 Ncm should change the plan in the room, not the reflection afterwards. The most useful thing nine studies taught me is that the single-villain story is comforting and usually wrong. The risk was rarely the one thing on the form. It was the patient, quietly carrying most of it, the way patients tend to.